ROEVER STEPHAN,WRIGHT MATTHEW,ROEVER Stephan,WRIGHT Matthew
申请号：
SI201030327
公开号：
SI2475645T1
申请日:
2010.09.08
申请国别(地区):
SI
年份:
2013
代理人:
摘要：
The present invention relates to a compound of formula I, in all its isomeric forms and pharmaceutically acceptable salts thereof, their manufacture, pharmaceutical compositions containing them and their use as medicaments for the treatment and/or prophylaxis of diseases which can be treated with HDL-cholesterol raising agents, such as dyslipidemia, atherosclerosis and cardiovascular diseases.
